StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CGC

Canopy Growth Corporation

CGC Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗
$0.96
+0.04 +4.32%

Key statistics

from XBRL data in SEC filings
Market cap
$404M
Revenue (TTM)
$285M
Net income (TTM)
-$189M
EPS (TTM)
$-0.88
P/E ratio
Dividend yield
Free cash flow
-$69.1M
Cash
$365M
Total assets
$1.12B
Gross margin
24.5%
52-week range
$0.84 – $2.38

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release) Jun 15, 2026 10-K Fiscal year ended 2026-03-31 Jun 15, 2026 8-K Amended charter or bylaws May 27, 2026 8-K Previously issued financials not reliable; Regulation FD disclosure May 15, 2026 8-K Regulation FD disclosure; Other events Mar 16, 2026 8-K Results of operations (earnings release) Feb 6, 2026 10-Q Quarter ended 2025-12-31 Feb 6, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 8, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Dec 15, 2025 8-K Results of operations (earnings release) Nov 7, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Shareholder vote results Oct 14, 2025 8-K Director or officer change; Regulation FD disclosure Sep 17, 2025 8-K Regulation FD disclosure; Other events Aug 29, 2025 8-K Results of operations (earnings release); Director or officer change Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 29, 2025 8-K Director or officer change; Regulation FD disclosure Jul 9, 2025 8-K Results of operations (earnings release) May 30, 2025 10-K Fiscal year ended 2025-03-31 May 30, 2025 8-K Other events Apr 1, 2025 8-K Other events Feb 28, 2025 8-K Results of operations (earnings release) Feb 7, 2025 10-Q Quarter ended 2024-12-31 Feb 7, 2025 8-K Other events Dec 10, 2024 8-K Unregistered sale of equity; Regulation FD disclosure Dec 9, 2024 8-K Director or officer change; Regulation FD disclosure Nov 26, 2024 8-K Results of operations (earnings release) Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Other events Oct 17, 2024 8-K Shareholder vote results Sep 25, 2024 8-K Director or officer change Aug 23, 2024 8-K Director or officer change; Regulation FD disclosure Aug 16, 2024 8-K Results of operations (earnings release) Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Other events Jun 6, 2024 8-K Other events Jun 5, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure; Other events Jun 5, 2024 8-K Results of operations (earnings release) May 30, 2024 10-K Fiscal year ended 2024-03-31 May 30, 2024